1 |
Vaccine industrialization in Korea: focus on major improvements and future directionVaccine industrialization in Korea: focus on major improvements and future direction
Jin Han Kang, Sung-Ho ChaJin Han Kang, Sung-Ho Cha
KMSID: 1059375 Clin Exp Vaccine Res. 2013;2(1):1-3. Published online 2013 January 15 DOI: http://dx.doi.org/10.7774/cevr.2013.2.1.1 |
|
4 |
Vaccines today, vaccines tomorrow: a perspectiveVaccines today, vaccines tomorrow: a perspective
Christian LoucqChristian Loucq
KMSID: 1059386 Clin Exp Vaccine Res. 2013;2(1):4-7. Published online 2013 January 15 DOI: http://dx.doi.org/10.7774/cevr.2013.2.1.4 |
|
8 |
Requirements for improved vaccines against foot-and-mouth disease epidemicsRequirements for improved vaccines against foot-and-mouth disease epidemics
Jong-Hyeon ParkJong-Hyeon Park
KMSID: 1059396 Clin Exp Vaccine Res. 2013;2(1):8-18. Published online 2013 January 15 DOI: http://dx.doi.org/10.7774/cevr.2013.2.1.8 |
|
19 |
The present and future of rabies vaccine in animalsThe present and future of rabies vaccine in animals
Dong-Kun Yang, Ha-Hyun Kim, Kyung-Woo Lee, Jae-Young SongDong-Kun Yang, Ha-Hyun Kim, Kyung-Woo Lee, Jae-Young Song
KMSID: 1059383 Clin Exp Vaccine Res. 2013;2(1):19-25. Published online 2013 January 15 DOI: http://dx.doi.org/10.7774/cevr.2013.2.1.19 |
|
26 |
H9N2 avian influenza virus in Korea: evolution and vaccinationH9N2 avian influenza virus in Korea: evolution and vaccination
Dong-Hun Lee, Chang-Seon SongDong-Hun Lee, Chang-Seon Song
KMSID: 1059384 Clin Exp Vaccine Res. 2013;2(1):26-33. Published online 2013 January 15 DOI: http://dx.doi.org/10.7774/cevr.2013.2.1.26 |
|
34 |
Current status of vaccine development for tularemia preparednessCurrent status of vaccine development for tularemia preparedness
Kee-Jong Hong, Pil-Gu Park, Sang-Hwan Seo, Gi-eun Rhie, Kyuh-Jam HwangKee-Jong Hong, Pil-Gu Park, Sang-Hwan Seo, Gi-eun Rhie, Kyuh-Jam Hwang
KMSID: 1059385 Clin Exp Vaccine Res. 2013;2(1):34-39. Published online 2013 January 15 DOI: http://dx.doi.org/10.7774/cevr.2013.2.1.34 |
|
40 |
Management of vaccine safety in KoreaManagement of vaccine safety in Korea
Young June Choe, Geun-Ryang BaeYoung June Choe, Geun-Ryang Bae
KMSID: 1059387 Clin Exp Vaccine Res. 2013;2(1):40-45. Published online 2013 January 15 DOI: http://dx.doi.org/10.7774/cevr.2013.2.1.40 |
|
46 |
Current status of registry of vaccine clinical trials conducted by Korean investigators in ClinicalTrials.gov, database of US National Institutes of HealthCurrent status of registry of vaccine clinical trials conducted by Korean investigators in ClinicalTrials.gov, database of US National Institutes of Health
Jahyang Cho, Bo Bae Kim, Chong-Woo Bae, Sung-Ho ChaJahyang Cho, Bo Bae Kim, Chong-Woo Bae, Sung-Ho Cha
KMSID: 1059388 Clin Exp Vaccine Res. 2013;2(1):46-52. Published online 2013 January 15 DOI: http://dx.doi.org/10.7774/cevr.2013.2.1.46 |
|
53 |
Perspectives on vaccine injury compensation program in Korea: the pediatricians' viewPerspectives on vaccine injury compensation program in Korea: the pediatricians' view
Dae Sun Jo, Jung Soo KimDae Sun Jo, Jung Soo Kim
KMSID: 1059389 Clin Exp Vaccine Res. 2013;2(1):53-57. Published online 2013 January 15 DOI: http://dx.doi.org/10.7774/cevr.2013.2.1.53 |
|
58 |
Inactivated pep27 mutant as an effective mucosal vaccine against a secondary lethal pneumococcal challenge in miceInactivated pep27 mutant as an effective mucosal vaccine against a secondary lethal pneumococcal challenge in mice
Sang-Yoon Choi, Thao Dang-Hien Tran, David E. Briles, Dong-Kwon RheeSang-Yoon Choi, Thao Dang-Hien Tran, David E. Briles, Dong-Kwon Rhee
KMSID: 1059390 Clin Exp Vaccine Res. 2013;2(1):58-65. Published online 2013 January 15 DOI: http://dx.doi.org/10.7774/cevr.2013.2.1.58 |
|
66 |
Prolonged shedding of the canine influenza H3N2 virus in nasal swabs of experimentally immunocompromised dogsProlonged shedding of the canine influenza H3N2 virus in nasal swabs of experimentally immunocompromised dogs
Minki Hong, Bokyu Kang, Woonsung Na, Dongjun An, Hyoungjoon Moon, Doo-Jin Kim, Jinsik Oh, Seong-Jun Park, Haryoung Poo, Jeong-Ki Kim, Jongman Kim, Daesub SongMinki Hong, Bokyu Kang, Woonsung Na, Dongjun An, Hyoungjoon Moon, Doo-Jin Kim, Jinsik Oh, Seong-Jun Park, Haryoung Poo, Jeong-Ki Kim, Jongman Kim, Daesub Song
KMSID: 1059391 Clin Exp Vaccine Res. 2013;2(1):66-68. Published online 2013 January 15 DOI: http://dx.doi.org/10.7774/cevr.2013.2.1.66 |
|
69 |
Clinical trials for vaccine development in registry of Korea Food and Drug AdministrationClinical trials for vaccine development in registry of Korea Food and Drug Administration
Seog-Youn KangSeog-Youn Kang
KMSID: 1059392 Clin Exp Vaccine Res. 2013;2(1):69-70. Published online 2013 January 15 DOI: http://dx.doi.org/10.7774/cevr.2013.2.1.69 |
|